Sanofi sues Glenmark, Torrent over sclerosis drug

Sanofi had received letters from Torrent and Glenmark, with a notice of their new drug applications

French drug maker Sanofi has sued Glenmark and Torrent Pharmaceuticals in a US court over their plans to launch a generic version of its multiple sclerosis drug, Aubagio.

Sanofi holds the patent for Aubagio and had global sales of euros 928 million in the first nine months of 2016. A majority of these sales were from the US, according to company filings.

The lawsuits against the two Indian companies comes in the wake of their applications to the US Food and Drug Administration to launch the generic version. 

Filed in a district court at Delaware on December 30, this was reported in the